Safety & Efficacy of Intranasal Dexmedetomidine, Fentanyl & Midazolam in the Pediatric Emergency Room
Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The hypothesis is that intranasal dexmedetomidine will provide significantly more effective
analgesia and anxiolysis for subjects undergoing a simple laceration repair when compared to
either intranasal fentanyl or intranasal midazolam.
Additional hypotheses include that there will be 1) no significant increase in adverse
effects between drugs and 2) significantly higher satisfaction rates for both subject
experience and ease of laceration repair based on structured, proceduralist feedback.